« Back to Record
Citation APA

Manson, G., Brice, P., Herbaux, C., Silva, M. G., Bouabdallah, K., Deau, B., Bouteloup, J., Schiano, J. M., Nicolas-Virelizier, E., Maerevoet, M., Ghesquieres, H., Stamatoullas, A., Antier, C., Carlo-Stella, C., de Charette, M., Poizeau, F., Dercle, L., & Houot, R. (2020). Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma. European journal of nuclear medicine and molecular imaging. doi:10.1007/s00259-020-05015-2


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/313021

Manson, G., Brice, P., Herbaux, C., Silva, M. G., Bouabdallah, K., Deau, B., Bouteloup, J., Schiano, J. M., Nicolas-Virelizier, E., Maerevoet, M., Ghesquieres, H., Stamatoullas, A., Antier, C., Carlo-Stella, C., de Charette, M., Poizeau, F., Dercle, L., & Houot, R. (2020). Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma. European journal of nuclear medicine and molecular imaging. doi:10.1007/s00259-020-05015-2